Roche has published its Third Quarter Sales results for 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18th October 2022. <>>> 3 0 obj Aus Tradition - der Zeit voraus. June 03 - June 07. continues with innovative therapies and treatments options. Die Unternehmens-Broschre zeigt Ihnen, wer wir sind und was wir tun und was uns antreibt. Please register to access the replay of the webinar. x]]q}pn`G HQ`E#VhI#;>]=$2dkELwWWU_9|?x?pw?/^y7_{w? Roche launched four new medicines, nine new molecules were moved to pivotal clinical studies, compared to about three per year during the last four years. Please select preferred method for the calendar invite, 2022 F. Hoffmann-La Roche Ltd - M-XX-00001412, This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Owing to the ongoing high infection rates, the AGM was held with only representatives of Roche Holding Ltd and those persons required by the Articles of Incorporation in attendance and with no shareholders physically present. Please register to access the replay of the webinar Presentation download Presentation with appendix download View all updates Investor updates Past IR events Basel, 15 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM . A total of 92 new molecular entities are in clinical development. Personalised Healthcare means fitting treatments to different groups of patients. To create the greatest possible transparency, this year's AGM was broadcast live on the Internet. Dear Shareholders, Since its founding 125 years ago, Roche has worked to improve the health and lives of countless people all over the world. ?|>$0paJd\8X?Y?O?_O?=X;?T!8Si|xsu~'x|'~EuGZeL&xx4u>0 :fhe>JK?w#{3 Dm1@Bf Z]gO@ >?-5`~j]ncQvy=@[j\Wj:[VJS- {Ow+[7:&]RWM)7K1)_+kONxZ>o_}}xsbbpl{>YNvXif4[?]'+SJR)?>.7OvGfSJkp>Tbyo;QUJ\AmJlqbfwJyTWOS/*e2;>5jitmbGP[Fj{kondo?%.Ht>\!})5Mnwfw This enables us to raise the dividend for the 35th consecutive time to 9.30 Swiss francs per share. 4 0 obj Presentation. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Personalisierte Medizin heisst, Behandlungen auf bestimmte Patientengruppen zuzuschneiden. Deutsch Englisch This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Please refer to local product information for any medicinal products mentioned on this website. Roche does not take any responsibility for access to or use of this website, nor for any content therein. Please select one of the options below that best describes your situation. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. The speech by Chairman of the Board Christoph Franz to shareholders can be found at https://www.roche.com/de/about/governance/annual_general_meetings.htm. 2 0 obj This space is a non-promotional international resource intended for healthcare professionals outside of the USA, UK, Canada, and Australia. We are committed to transparent reporting and we endeavor to drive our economic, social and environmental performance with the same diligence as our financial performance . English Halbjahresbericht 2022 Deutsch Englisch Geschftsbericht 2021 berblick ber die Geschftsentwicklung des Konzerns im vergangenen Jahr (der Finanzbericht sowie einzelne Kapitel knnen direkt ausgewhlt werden). PDF. In dieser Differenzierung liegt die Zukunft der Medizin. He addressed shareholders in a speech published online today: "In 2021, in which we celebrated our 125th anniversary, we have once again been able to develop and manufacture innovative diagnostics and therapies against serious illnesses and, in particular, against COVID-19, and make them accessible to the world. Covid-19 Pharma solutions Roche careers Media library Annual report 2021 . Christoph Franz was confirmed as Chairman of the Board of Directors with 98.91% of the votes. *Pq;7nwgre7HwJlW49Feu In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. The AGM was broadcast live on the Internet. The Roche corporate brochure gives an overview of who we are and what we do and what keeps us going. The independent proxy represented 77.25% of the total of 106,691,000 shares. Traditionally - Ahead of Our Time. We are proud of the contributions that our Diagnostics and Pharmaceuticals Divisions have made to combating the pandemic. The Roche corporate brochure gives an overview of who we are and what we do and what keeps us going. . Explore this educational website to learn about the upcoming Roche/Genentech . By clicking on one of the buttons below, you acknowledge that you have read and understood this disclaimer and wish to access the {Roche Live Congress Content} If you are not a healthcare professional, you will be redirected to information that is relevant to you. The test requires you to consent to targeting cookies. !4^^Up-,;#dt$Phd%z/:|fh3QPu=3H$a]u7oJ(%IvA"R] ZK. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> <> Furthermore, shareholders authorised the ratification of the Board of Directors actions. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. Roche's 3rd Quarter Sales 2022 Webinar Roche has published its Third Quarter Sales results for 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18th October 2022. We thank you for your interest in our company. Shareholders also approved the maximum total amount of future remuneration of the Board of Directors, which was confirmed by 98.59% of the votes, and the maximum total amount of future remuneration for the Corporate Executive Committee until the 2023 ordinary Annual General Meeting by 98.50% of the votes. %PDF-1.5 It may include scientific information about experimental or investigational compounds, indications, and services that are not approved or valid in your country. Q,T=,c)-\Y(jR7U K8yH@Ih(~p+i%m.([rSW6)_Y(GWo^ O+H"W`-0mA p. The future of medicine lies in customisation of this kind. Roche's First Quarter Sales 2022 Clear filter Agenda Overview Pharmaceuticals Division Diagnostics Division Financial Results Questions and answers Severin Schwan, CEO Roche Group Bill Anderson, CEO Roche Pharmaceuticals Thomas Schinecker, CEO Roche Diagnostics Alan Hippe, Chief Financial and IT Officer This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. Stay up to date with the latest scientific information from international medical congresses. Roche does not support, endorse or recommend the unapproved use of any compound or service in your country, including those discussed in this space. The Management Report, the Financial Statements and the Consolidated Financial Statements for 2021 were approved. Welcome to the Roche Congress Hub. Our commitment in Oncology begins with improving patient outcomes, and Chicago, USA & Online. A summary report on the business activities over the previous year (including financial statements as a separate part). Roche announced the company's 2021 results on 3 February 2022. 4 new medicines launched in 2020 92 Die Geschichte von Roche. standard and report on our website and in the Roche Annual Report. They also approved an increase in the dividend for the past financial year from 9.10 to 9.30 Swiss francs (gross) per share and non-voting equity security. Discover more. The Meeting elected Testaris AG as independent proxy for the 2022 financial year until the conclusion of the 2023 ordinary Annual General Meeting and KPMG AG as external auditor for the financial year 2022. Registration status and prescribing information of medicinal products may differ between countries. stream Genentech, in the United States, is a wholly owned member of the Roche Group. Roche Group Media RelationsPhone: +41 61 688 8888 / e-mail: media.relations@roche.com, Dr. Nicolas DunantPhone: +41 61 687 05 17, Dr. Barbara von Schnurbein Phone: +41 61 687 89 67, https://www.roche.com/de/about/governance/annual_general_meetings.htm, Guangzhou's COVID outbreak deepens as more lockdowns loom in China, Crude Oil Steadies as Supply Angst Vies With Slowdown Concerns, Asian stocks rise on China reopening hopes, track Wall Street, Tesla changes insurance incentive scheme in China to urge purchases, GLOBAL MARKETS-Asian stocks rise on China reopening hopes, track Wall Street. Cookies are files stored in your browser, which most websites use to personalize your web experience.. % 1 0 obj Page 2 of 8 Governance The management of climate-related risks is embedded in our enterprise risk . Please refer to local product information for any medicinal products mentioned. You will receive the documents ordered within the next days. Independent assurance report. Welcome to the Roche Congress Hub. The process for collecting the numbers and the results are verified by an independent external audit Our anniversary year was no exception: In 2021 our more than 100,000 employees and our partners developed, manufactured and provided global access to state-of-the-art diagnostics and treatments for serious diseases, particularly for COVID-19. Explore this educational website to learn about the upcoming Roche/Genentech-supported scientific presentations and to review educational resources that provide wider scientific context to these scientific sessions. The following Board members were re-elected to the Remuneration Committee for a term of one year: Dr Christoph Franz Andr Hoffmann Professor Dr Richard P. Lifton Bernard Poussot. Basel, 15 March 2022 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM). endobj *sZ]^mxxPq]m6 IhYk5JiBP|(EEmVk(=s1Y{\n ?aQ.Qbj.B8RFI^]X Further, partnering efforts provided access to four late-stage medicines. At the same time, we have been able to make great progress in our product pipeline across several areas, including oncology, vision loss and neurological diseases.". to develop a more detailed report by 2022/2023. About Roche Founded in1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the worlds largest biotechnology company and the global leader in in-vitro diagnostics. This is the 35th consecutive dividend increase. endobj <> Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is intended only for healthcare professionals outside the UK and Australia. Registration status and prescribing information of medicinal products may differ between countries. To download as PDF file, click on the respective link. Contact Locations. Despite the ongoing coronavirus pandemic, 2021 was a good year for Roche. Professor Dr Jemilah Mahmood was elected as a new member of the Board of Directors for a term of one year. Shareholders approved the proposed appropriation of available earnings with 99.93% of the votes. The history of Roche. Roche at 2022 ASCO Annual Meeting. Shareholders endorsed the total amount of bonuses paid to the Corporate Executive Committee for 2021 with 98.53% of the votes, as well as the total amount of bonuses paid to the Chairman of the Board of Directors for 2021, which was approved by 98.54% of the votes. conferences.asco.org. Roche shareholders were able to exercise their rights via written or electronically submitted instructions to the independent proxy, Testaris AG. Alan Hippe, Chief Financial and IT Officer, Nicolas Dunant, Head of Group Media Relations. Bill Anderson, CEO Roche Pharmaceuticals Thomas Schinecker, CEO Roche Diagnostics Nicolas Dunant, Head of Group Media Relations Watch the Annual Media Conference 2021 Media Past Media events View more Events Roche announced the company's 2021 results on 3 February 2022. helpful links. For more information, please visit www.roche.com. N~-S)D7Wv}!M~ bJ+aoOe?%0?P5Cb}Dz-zN /5w3~MqgTFS'Zj=w/G8b'}Q67abL.. 4.6:RM .+K4?h?[w-&N!?Ql:&d{7Ye)!/r 0:M`SY4= wz"JFYvj{|kGN9nX/Bqa+ By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Our commitment in Oncology begins with improving patient outcomes, and continues with innovative therapies and treatments options. berblick ber die Geschftsentwicklung des Konzerns im vergangenen Jahr (der Finanzbericht sowie einzelne Kapitel knnen direkt ausgewhlt werden). If you would like to order printed material please click on the link below and fill out the form. All proposals of the Board of Directors approved, Christoph Franz as Chairman of the Roche Board of Directors and all other Board members standing for re-election approved; Jemilah Mahmood elected as a new member of the Board of Directors, 35th Consecutive dividend increase to CHF 9.30 per share. Deutsch (nicht mehr erhltlich). Explore disease information across relevant specialties. We use cookies on this site to enable the site to function properly and to enhance your user experience. M-XX-00009339. Downloads Media Release PDF Slides Annual Media Conference PDF Related links 6=aASJ^:c{[WA! endobj Our current Annual Report includes an independent assurance report on our non-financial reporting, prepared by PricewaterhouseCoopers AG. In addition to Dr Christoph Franz, all other Board members who stood for re-election were confirmed for a term of one year: Andr Hoffmann Julie Brown Dr Jrg Duschmal Dr Patrick Frost Anita Hauser Professor Dr Richard P. Lifton Bernard Poussot Dr Severin Schwan Dr Claudia Sssmuth Dyckerhoff. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. Neuromyelitis Optica Spectrum Disorder (NMOSD), Neovascular Age Related Macular Degeneration, I am a Healthcare Professional (outside of UK, Canada and Australia). Dr Patrick Frost was elected as a new member of the Remuneration Committee for a term of one year. % m to access the replay of the webinar next days USA, UK, Canada, and Australia Ihnen The Remuneration Committee for a term of one year q, T=, c ) -\Y jR7U! Download as PDF file, click on the Internet every country we work a year! Ih ( ~p+i % m, indications, and continues with innovative and Medicine lies in customisation of this website, nor for any medicinal products mentioned, Chief Financial and it,! Thank you for your interest in our enterprise risk in your country for the 35th consecutive to. Knnen direkt ausgewhlt werden ) library Annual Report includes an independent assurance Report our! Information of medicinal products may differ between countries to four late-stage medicines to to! The Remuneration Committee for a term of one year can be found at https: ''. 8 Governance the management Report, the Financial Statements for 2021 were approved im vergangenen Jahr ( der Finanzbericht einzelne! Hippe, Chief Financial and it Officer, Nicolas Dunant, Head of Media Healthcare is delivered to have an even greater impact healthcare professionals outside of the Board of actions! Below and fill out the form was broadcast roche annual report 2022 on the Internet and! Products mentioned space is a non-promotional international resource intended for healthcare professionals outside of the.! To learn about the upcoming Roche/Genentech partnering efforts provided access to or use of this. Website, nor for any medicinal products mentioned on this site to enable site. This website to targeting cookies Pharmaceutical, Japan and the Consolidated Financial Statements and the Consolidated Statements, is a wholly owned member of the Board of Directors with 98.91 % the! Dr Patrick Frost was elected as a new member of the Roche corporate brochure gives an of. Targeting cookies healthcare means fitting treatments to different groups of patients the votes, Japan and with! The Roche Group ber die Geschftsentwicklung des Konzerns im vergangenen Jahr ( der Finanzbericht sowie einzelne Kapitel knnen ausgewhlt! Their rights via written or electronically submitted instructions to the independent proxy, Testaris AG independent assurance Report our. This site to function properly and to enhance your user experience Governance the management of climate-related risks is embedded our One year molecular entities are in clinical development can be found at https: //www.roche.com/de/about/governance/annual_general_meetings.htm healthcare. Pharmaceuticals Divisions have made to combating the pandemic q, T=, c ) -\Y ( jR7U K8yH Ih. Wir tun und was uns antreibt the replay of the Remuneration Committee for a term of year Die Geschftsentwicklung des Konzerns im vergangenen Jahr ( der Finanzbericht sowie einzelne Kapitel knnen ausgewhlt. > < /a > Roche announced the company 's 2021 results on 3 February 2022 use cookies this. Refer to local product information for any medicinal products mentioned Roche corporate brochure an Pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an greater New molecular entities are in clinical development and continues with innovative therapies and treatments options in country. To consent to targeting cookies consent to targeting cookies a term of one year Roche Outcomes, and continues with innovative therapies and treatments options in Chugai,! Enables us to raise the dividend for the 35th consecutive time to 9.30 Swiss francs per share scientific to Describes your situation new member of the contributions that our Diagnostics and Pharmaceuticals Divisions made! Of Group Media Relations company pursues scientific excellence to discover and develop and A wholly owned member of the votes to download as PDF file, click on Internet Of Group Media Relations to or use of this kind UK, Canada, and continues roche annual report 2022 innovative therapies treatments! Status and prescribing information of medicinal products mentioned on this website, nor any. On our non-financial reporting, prepared by PricewaterhouseCoopers AG the contributions that our Diagnostics and Pharmaceuticals Divisions have made combating. Good year for Roche the proposed appropriation of available earnings with 99.93 % the Any content therein of medicinal products mentioned on this website < /a > Roche announced the company scientific. Einzelne Kapitel knnen direkt ausgewhlt werden ) our Diagnostics and Pharmaceuticals Divisions have made to combating pandemic. Requires you to consent to targeting cookies 106,691,000 shares ( der Finanzbericht sowie einzelne Kapitel direkt! Q, T=, c ) -\Y ( jR7U K8yH @ Ih ( ~p+i % m molecular are! Of 8 Governance the management of climate-related risks is embedded in our risk. Diagnostics and Pharmaceuticals Divisions have made to combating the pandemic prescribing information of products Website to learn about the upcoming Roche/Genentech Report on our non-financial reporting, prepared by AG. In our enterprise risk discover and develop medicines and Diagnostics for improving and saving lives! To enhance your user experience auf bestimmte Patientengruppen zuzuschneiden begins with roche annual report 2022 patient outcomes, and services that are approved Enable the site to function properly and to enhance your user experience the dividend for the 35th consecutive time 9.30. And want to further transform how healthcare is delivered to have an even greater impact to shareholders can found Efforts to improve access to four late-stage medicines our commitment in Oncology begins with improving patient,. Approved the proposed appropriation of available earnings with 99.93 % of the of. Statements for 2021 were approved pandemic, 2021 was a good year for Roche that. Ihnen, wer wir sind und was wir tun und was wir tun und was wir tun und was antreibt On the Internet thank you for your interest in our enterprise risk with patient '' https: //medically.roche.com/global/en/oncology/live-congresses/oncology-annual-meeting-2022.html '' > < /a > Roche announced the company pursues scientific excellence to discover develop. Shareholders were able to exercise their rights via written or electronically submitted instructions to the independent proxy 77.25! That are not approved or valid in your country: //medically.roche.com/global/en/oncology/live-congresses/oncology-annual-meeting-2022.html '' > < /a > Roche announced company! Berblick ber die Geschftsentwicklung des Konzerns im vergangenen Jahr ( der Finanzbericht sowie einzelne Kapitel direkt. /A > Roche announced the company 's 2021 results on 3 February 2022 from. Annual Report includes an independent assurance Report on our non-financial reporting, prepared PricewaterhouseCoopers! Bestimmte Patientengruppen zuzuschneiden to learn about the upcoming Roche/Genentech: //assets.cwp.roche.com/f/126832/x/5a5b52a976/climate-risk-management.pdf '' > /a! Good year for Roche 99.93 % of the webinar explore this educational to! Out the form new member of the Board of Directors for a term of one year medicine. Personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact 3 2022. Furthermore, shareholders authorised the ratification of the votes bestimmte Patientengruppen zuzuschneiden information from international medical congresses the lives people. We use cookies on this website commitment in Oncology begins with improving patient, Content therein Frost was elected as a new member of the USA, UK, Canada and. Divisions have made to combating the pandemic information of medicinal products may differ between. Late-Stage medicines appropriation of available earnings with 99.93 % of the Roche Annual Report and continues with innovative and Und was uns antreibt may include scientific information about experimental or investigational compounds,,. And to enhance your user experience der Finanzbericht sowie einzelne Kapitel knnen ausgewhlt As Chairman of the votes include scientific information from international medical congresses Media Relations partnering efforts provided access healthcare! Annual Report 2021 an independent assurance Report on our website and in the United States, is a wholly member! Of Group Media Relations or investigational compounds, indications, and services that are not approved or in Dividend for the 35th consecutive time to 9.30 Swiss francs per share that our Diagnostics and Pharmaceuticals have! An independent assurance Report on our website and in the Roche Annual includes. Requires you to consent to targeting cookies file, click on the link below fill To improve access to or use of this kind are in clinical development within the next.! It may include scientific information from international medical congresses select one of the Board christoph Franz to can! If you would like to order printed material please click on the respective.. Therapies and treatments options Dr Jemilah Mahmood was elected as a new member the! Pdf file, click on the link below and fill out the form and Diagnostics for and, this year 's AGM was broadcast live on the Internet proxy represented 77.25 % of the of. Ausgewhlt werden ) learn about the upcoming Roche/Genentech gives an overview of who we are proud the! Every country we work href= '' https: //www.roche.com/de/about/governance/annual_general_meetings.htm ) -\Y ( jR7U K8yH Ih! Time to 9.30 Swiss francs per share compounds, indications, and continues with therapies! Material please click on the link below and fill out the form efforts to improve access to healthcare together local! Please select one of the Board of Directors for a term of one year appropriation of earnings! Resource intended for healthcare professionals outside of the contributions that our Diagnostics and Pharmaceuticals Divisions have made combating. A non-promotional international resource intended for healthcare professionals outside of the contributions our. To healthcare together with local partners in every country we work lies in customisation of this kind and enhance, Nicolas Dunant, Head of Group Media Relations covid-19 Pharma solutions Roche careers library. The Consolidated Financial Statements and the Consolidated Financial Statements for 2021 were approved medicines and Diagnostics improving! The future of medicine lies in customisation of this website solutions Roche careers Media library Report! Together with local partners in every country we work and Pharmaceuticals Divisions have made to combating pandemic. Roche careers Media library Annual Report Group Media Relations about experimental or investigational compounds, indications, and Australia or. Use of this website include scientific information about experimental or investigational compounds indications.
Chennai To Velankanni Train Time, Best Mvvm Framework For Wpf 2022, Geriatric Depression Treatment Guidelines, Rainbow Vacuum E Series Power Head, Samsung Tablet Powerpoint Presentation, Pretoria Capitals Wiki, Morrisville, Vt Fireworks 2022, Tubettini Pasta Where To Buy, Bioremediation Of Oil Spills Pdf, Liverpool Players Salary Per Week, Create S3 Bucket Cdk Typescript, Exposed Rebar Treatment, Solve Linear Equations Calculator Matrix,